LAWSON JOHN DAVID,LAWSON JOHN DAVID,SABAT MARK,SABAT MARK,SCORAH NICHOLAS,SCORAH NICHOLAS,SMITH CHRISTOPHER,SMITH CHRISTOPHER,VU PHONG H.,VU PHONG H.,WANG HAIXIA,WANG HAIXIA
申请号：
PL14719130
公开号：
PL2970202T3
申请日:
2014.03.10
申请国别(地区):
PL
年份:
2017
代理人:
摘要：
Disclosed are compounds of Formula 1, or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, and R4 are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of Formula 1, to pharmaceutical compositions which contain them, and to their use for treating Type I hypersensitivity reactions, autoimmune diseases, inflammatory disorders, cancer, non-malignant proliferative disorders, and other conditions associated with BTK.
